3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Conditions
Carcinoma, Hepatocellular
20
Carcinoma, Renal Cell
16
Liver Neoplasms
7
Leukemia, Myeloid, Acute
3
Thyroid Neoplasms
2
Financial Stress
2
Carcinoma
2
Patient Preference
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Adenoma, Islet Cell
1
Interventions
Surveys and Questionnaires
7
COVID-19 Vaccines
4
Surgical Procedures, Operative
3
Specimen Handling
3
Blood Specimen Collection
3
Pandemic Preparedness
2
Data Collection
2
BNT162 Vaccine
2
2019-nCoV Vaccine mRNA-1273
2
sinovac COVID-19 vaccine
1
regorafenib
1
heterologous prime boost COVID-19 vaccination
1
Telemedicine
1
Sorafenib
1
Serologic Tests
1
Patient Reported Outcome Measures
1
Meopa
1
Mastectomy, Segmental
1
High-Throughput Nucleotide Sequencing
1
Drug Therapy
1
Colonoscopy
1
Ad26COVS1
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
COVID-19
×
Sorafenib
×
Clear all
NCT05594147
2023-11-07
ROCURS
Bayer
Completed
4,103 enrolled